🧠 #EAN2025@EANeurology outlines its 10-year strategic plan for neurology in Europe:
1️⃣ National brain health plans
2️⃣ Structured patient care
3️⃣ Interventional neurology
4️⃣ AI in clinics
5️⃣ Stronger neuro hubs
6️⃣ Research & innovation
7️⃣ Patient participation
The future of neurology is now.
#Neurology #Helsinki #BrainHealth
Join us at @MissionMSA’s 2025 International MSA Congress! AskBio's symposium on #GeneTherapy and MSA: Exploring Innovation Through Science and Patient Perspectives will be held on Saturday, May 10 from 3:30-5:00pm..
Learn more about #MSA2025: https://t.co/kx3NgIPtGb
Precision medicine starts with biomarker testing—discover how it can lead to targeted treatments tailored to you 👉 https://t.co/sfkGeEc9F0 #CancerCare#PrecisionMedicine
Educational content supported by Bayer.
#BiomarkerTesting helps cancer survivors find personalized treatment options, bringing #hope & precision to their cancer journey! 🌟 Learn how two survivors used this powerful tool for better outcomes.
LCRF is pleased to announce its collaboration with Bayer Pharmaceuticals to fund two research grants focused on innovative strategies to advance understanding and management of #LungCancer with HER2 mutations and/or other HER2 alterations. Find out more at https://t.co/4daMqHMS3e
Researchers at MIT have questioned whether SMART goals (specific, measurable, achievable, realistic, time-bound) actually work. They suggest we might get better outcomes if we make our goals FAST (frequently discussed, ambitious, specific and transparent) not SMART.
It is with great sadness that we say good-bye to our dear friend and powerful lung cancer advocate, Ivy Elkins. We will remember Ivy as vibrant, compassionate, and unselfish; never defined by her cancer, and always proving that she was a person, not a statistic.
Only 4% of evidence based guidelines mention patient preferences. @EnriqueSoto8 on decision making for older adults but message applies to all - ASK, ASK, ASK!
And we MUST add pt pref to evidence guidelines- pts are the only reliable source of data on their preferences!
#ASCO24
Day 2 at @ASCO started out strong with a powerful conversation among advocates and @BayerPharma . If we all work together anything is possible! Thank you @DrMerchant for all you do for us patients and survivors! 💙#ASCO24
As we anxiously await data to read out at #ASCO24, please remember, People Come First!
@MaryBoulanger4 will present her work that highlights prognostic communication challenges & patients' unmet psychosocial needs - both JUST AS IMPORTANT as OS & HR's.
https://t.co/KDEqiNMUw4
Y’all!!! The #clinicaltrial video (part I) I made for Bayer a few weeks ago was picked up by OncoDaily. An unexpected delight! Take a 👀 👉���� https://t.co/YuUUKBQbCI
Thank you bunches @BayerOncMed & @oncodaily for amplifying my content for #NationalMinorityHealthMonth 💗🙌🏽